Adrenaline, 3-isobutyl-1-methylxanthine (MIX) and dibutyryl cyclic AMP (Bt2 cyclic AMP) stimulated type-L hormone-sensitive lipase (HSL) activity when measurements were made on defatted rat heart powders. These lipolytic agents stimulated the activity of this enzyme in a time-and dose-dependent manner. This activation was reversible, because removal of adrenaline from the perfusate was accompanied by the return of type-L HSL activity to control levels. We have reported [Palmer, Caruso & Oscai (1981) Biochem. J. 198, 159-1661 that perfusion with low levels of adrenaline, MIX or Bt2 cyclic AMP reduced type-L HSL activity below control levels when measurements were made in aqueous homogenates. However, in the present study, when activities were measured in acetone/diethyl ether heart powders, all concentrations of these agents studied stimulated enzyme activity, and at no concentration was there enzyme inhibition. These data suggest that acetone/diethyl ether treatment may remove a factor that plays a role in type-L HSL regulation. Type-L HSL activity measured in acetone/diethyl ether powders of control and stimulated rat heart exhibited properties that include alkaline pH optimum, serum requirement, activation by heparin and inhibition by high salt and protamine sulphate. These characteristics, in addition to the stability of the enzyme to treatment with organic solvents, fulfil the requirements for the type-L HSL classification.
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Hormonal stimulation of cardiac lipolysis is well documented (Gartner & Vahouny, 1972; Crass et al., 1975) . Recently, we showed that the heparin non-releasable fraction, hypothesized to be the intracellular fraction , of lipoprotein lipase was activated and inhibited by cyclic AMP (Palmer et al., 1981) . High concentrations of agent stimulated enzyme activity, whereas low concentrations of nucleotide inhibited lipase activity. The activity of this enzyme related closely to both the level of intracellular triacylglycerol, as well as the concentration of non-esterified fatty acid in the tissue. The activity, measured in crude aqueous heart homogenate, was sensitive to heparin, protamine sulphate and NaCl. Control and stimulated lipase activities had a serum requirement and a pH optimum of 8.1. Since there are no plasma lipoproteins in heart parenchymal cells, and because hormone sensitivity has been demonstrated, this lipase has been termed type-L (having characteristics of the lipoprotein lipase) HSL (Palmer, 1983 (Robinson, 1970) . In fact, investigators (Salaman & Robinson, 1966; Borensztajn et al., 1972; Huttunen et al., 1972) have taken advantage of this property by using it to characterize LPL and separate this enzyme from other organic-solvent-labile lipases. Since previous measurements on activated type-L HSL have been performed on aqueous homogenates (Oscai, 1979; Palmer et al., 1981) (Kotlar & Borensztajn, 1977) . At the time of killing, the rats weighed approx. 230g. After overnight starvation, the rats were anaesthetized with sodium pentobarbital (60mg/kg body wt.) and killed by removing the heart.
Heart perfusion and tissue preparation Hearts were isolated and perfused for 4min at a rate of 6 ml/min with Krebs-Ringer bicarbonate (KRB) buffer (pH 7.4) containing 5% (v/v) At the end of the perfusion period, hearts were weighed, minced and homogenized in 20vol. of cold acetone by using a Polytron homogenizer. The homogenate was filtered through Whatman filter paper (no. 1) and subsequently washed with 150 ml of cold acetone, 250ml of room-temperature acetone and 250ml of room-temperature diethyl ether. Filter papers containing the heart powders were then freeze-dried for 30min.
Lipase assay
Enzyme activity was measured by using the classical lipoprotein lipase assay described by Borensztajn et al. (1972) . Defatted heart powders were homogenized (10mg/ml) in 25mM-NH3/HCl buffer (pH 8.1) with a Duall ground-glass tissue grinder (Kontes Glass Co., Evanston, IL, U.S.A.). Type-L HSL activities are expressed as units +S.E.M.; 1 unit of activity released 1 pmol of non-esterified fatty acid into the assay medium/h of incubation. The assays were linear with time and protein content regardless of tissue treatment.
Results
The lipolytic agents adrenaline, MIX and Bt2 cyclic AMP stimulated type-L HSL activity even when measurements were made on defatted rat heart powders (Figs. 1 and 2; Table 1 ). Fig. 1 shows that adrenaline stimulated type-L HSL activity of perfused hearts when hearts were assayed after treatment with organic solvents. The activation is time-dependent, with maximal stimulation being attained at 15 min of perfusion when 0.005, Madrenaline was utilized. When higher concentrations of adrenaline were used, maximal activity was attained more rapidly than shown in Fig. 1 . For example, 1.0,uM-adrenaline fully stimulated type-L HSL activity with only 3 min of perfusion. When less than 0.005#uM-adrenaline was contained in the perfusate, type-L HSL activity reached a plateau at a lower level than that seen in Fig. 1 (approx. 450units/g of powder).
When adrenaline was removed from the flowthrough perfusion system, at 15min, the activity returned to control levels by 45min of perfusion.
Restimulation of the perfused heart with adrenaline again stimulated type-L HSL to the same activity that was attained when the heart was perfused continuously for 50min with adrenaline. When hearts were perfused with various amounts of the cyclic AMP phosphodiesterase inhibitor, MIX, type-L HSL activity, measured in defatted heart powders, was stimulated in a dose-dependent manner until a perfusate concentration of 230pM was reached (Table 1) . Increasing the amount of MIX did not increase enzyme activity to any greater extent. Fig. 2 shows that when 230#M-xanthine was of -perfusion stimulated type-L HSL activity to 417 + 11 units/g of powder.
Perfusion of the hearts with Bt2 cyclic AMP stimulated type-L HSL activity in a dose-dependent manner. The data in Fig. 2 show the time-course of enzyme activation when perfusing with lO,uM-Bt2 cyclic AMP. Enzyme activation was more rapid than that seen for adrenaline (Fig. 1) or MIX (Fig. 2) .
When the type-L HSL was measured in whole homogenates, lipolytic agents had a biphasic effect on enzyme activity (Palmer et al., 1981) . In Table 2 , it is evident that a different response is seen when assays are performed on acetone/diethyl ether powders than when analyses are made on aqueous homogenates. Table 2 has been constructed from data published previously (Palmer et al., 1981) and analysis of acetone/diethyl ether preparations of rat heart. Perfusion with low levels of lipolytic agent significantly decreased type-L HSL activity when measurements were made on aqueous homogenates. However, when hearts were perfused with the same concentrations of adrenaline, MIX or Bt2 cyclic AMP, and measurements made on acetone/diethyl ether powders, enzyme activity was stimulated. In fact, at no time have we experienced an inhibitory influence by lipolytic agent on type-L HSL activity when measurements were made on defatted heart powders. used, the time-course of type-L HSL activation was similar to that for the adrenaline concentration shown in Fig. 1 (1981) . Although the perfusion conditions differed slightly in that work (30min rather than 15min), the activities measured for acetone/diethyl ether preparation of heart were the same at 15 and 30min (see Fig. 2 
* Significantly less than control aqueous homogenate activity (P < 0.001).
t Significantly greater than control defatted powder activity (P < 0.001).
To determine if the control and stimulated type-L HSL activity exhibited properties similar to that seen in aqueous heart homogenate, we characterized the control and stimulated type-L HSL activity measured in defatted heart powders. The data in Table 3 show the effect of inclusion of 1 M-NaCl or 1 mg of protamine sulphate/ml in the assay. In addition, the dependence of enzyme activity on serum was determined. Removal of serum from the assay was associated with greater than 90% decrease in enzyme activity regardless of whether the hearts were stimulated or non-stimulated. Inclusion of 1 M-NaCl in the assay showed a similar inhibitory effect. Protamine sulphate addition to the assay reduced enzyme activity found in acetone/diethyl ether heart powders of control and stimulated hearts to approximately the same level of activity (approx. 45 units/g of powder). It can be seen in Table 4 that only 53% of the control activity could be measured when no heparin was present in the assay. When hearts were stimulated with adrenaline, MIX or Bt2 cyclic AMP, removal of heparin from the assay decreased activity 41%, 57% and 54% respectively. Inclusion of a 4-fold increase in heparin in the assay was associated with approximately a 20% reduction in type-L HSL activity in control samples and less than a 10% reduction in activity in the stimulated rat heart powders. Maximal type-L HSL activity was measured when 1 unit of heparin/ml was in the assay.
It is evident from the data in Table 5 that enzymic activity could be measured in a wide pH range. However, maximal activity was measured at a pH optimum of 8.1 in the acetone/diethyl ether powders of control and stimulated hearts. At a pH of 7.4 adrenaline only increased enzymic activity 18% heart homogenates. Oscai (1979) showed that there was increased activity in the heparin-non-releasable fraction of aqueous heart homogenates. The elevated enzyme activity was accompanied by a reduction in cardiac triacylglycerol concentration. Subsequently, Palmer et al. (1981) In the present study, it was possible to demonstrate hormone sensitivity of type-L HSL. However, the biphasic effect of lipolytic agents disappears when hearts are delipidated with organic solvents. Removal of the inhibitory effect of low doses of lipolytic agent by treatment with acetone/diethyl ether may suggest that a type-L HSL inhibitor is being removed that may play a role in the regulation of this enzyme.
Sutherland has proposed a list of criteria for determining when a hormone-induced event is mediated by cyclic AMP (Robison et al., 1971) . In the present study, stimulation of type-L HSL activity by adrenaline, a hormone shown to increase cardiac cyclic AMP levels (Robison et al., 1968) , and by perfusion with Bt2 cyclic AMP fulfil two of Sutherland's criteria. When type-L HSL activity was measured in acetone/diethyl ether powders of hearts perfused with submaximal amounts of adrenaline and MIX, these two agents yielded higher activity than could be elicited by either agent alone. The synergistic potentiation of the hormone's effect by administration of the cyclic AMP phosphodiesterase inhibitor suggests that the activation of type-L HSL is mediated directly or indirectly by cyclic AMP.
In 1955, Korn (1955a) identified specific characteristics of an acetone-stable lipase in the heparin non-perfused rat heart. These characteristics are now used to identify lipoprotein lipase. These properties included enzyme sensitivity to heparin, high salt and protamine. Korn & Quigley (1957) determined that the pH optimum for the enzyme activity was 8.1. Serum (Korn, 1955b) , and particularly serum apolipoprotein C-II (Lukens & Borensztajn, 1978) , has been identified as a potent stimulator of lipoprotein lipase. We have used these properties to characterize a hormone-stimulated lipase identified in heparin-perfused (intracellular fraction) rat heart. Activity measured in acetone/ diethyl ether powders from control hearts and hearts stimulated with the lipolytic agents adrenaline, MIX and Bt2 cyclic AMP exhibited the common properties, including an alkaline pH optimum, serum requirement, activation by heparin and inhibition by high salt and protamine sulphate. Since hormone stimulation of lipase activity could be identified in acetone/diethyl ether powders of rat heart, and because the elevated activity had the characteristics described, the findings reported in the present paper are consistent with the type-Ldesignation ofthis HSL.
Although the concept has developed that lipoprotein lipase functions exclusively as a clearing factor responsible for the hydrolysis of triacylglycerol in the circulation (Robinson, 1970; Borensztajn, 1975) , it is becoming apparent that the intracellular fraction of lipoprotein lipase (type-L HSL) functions as a regulator of triacylglycerol concentration in the rat myocardium. The action of lipolytic agents on this enzyme seems to be mediated directly or indirectly through cyclic AMP.
